Mark E Saad is Director of Ra Medical Systems, Inc.. Currently has a direct ownership of 13,750 shares of RMED, which is worth approximately $5,225. The most recent transaction as insider was on Jan 05, 2021, when has been sold 8,227 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.8K
0% 3M change
0% 12M change
Total Value Held $5,225

Mark E Saad Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2021
Grant, award, or other acquisition
8,227 Added 37.43%
13,750 Common Stock
Oct 12 2020
Grant, award, or other acquisition
100,000 Added 42.0%
138,085 Common Stock

Also insider at

Axsome Therapeutics, Inc. Healthcare

Mark E Saad

New York, NY

Track Institutional and Insider Activities on RMED

Follow Ra Medical Systems, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RMED shares.

Notify only if

Insider Trading

Get notified when an Ra Medical Systems, Inc. insider buys or sells RMED shares.

Notify only if


Receive news related to Ra Medical Systems, Inc.

Track Activities on RMED